Aspira women's health partners with dorsata to offer access to 300+ women's health practices, 1.5 million + new patients

Aspira and dorsata launch clinical workflow tool for adnexal masses, now live for all dorsata clients, adnexal mass evidence-based decision support austin, tx and washington, dc / access newswire / june 17, 2025 / aspira women's health inc. a bio-analytical-based women's health company focused on gynecologic disease diagnostics, and dorsata, a leading clinical decision-support and provider workflow platform for women's health, announced today the official launch of a new adnexal mass clinical decision support module in partnership with dorsata, a leading women's health electronic health record software solutions company. dorsata's platform is currently used by more than 700 women's health providers across over 300 practice sites in 20 states, helping clinicians standardize care delivery and improve outcomes through guided clinical workflows and real-time decision support for over 1.5 million patients each year.
AWH Ratings Summary
AWH Quant Ranking